Clinical Evaluation of HeartPoint Global Intellistent for Pulmonary Flow Adjustment in Congenital Heart Disease and Dilated Cardiomyopathy
IntelliStent is intended to achieve reduction of pulmonary hypertension, improvements in symptoms and quality of life in pediatric, adolescent and adult patients with congenital heart disease associated pulmonary arterial hypertension or left ventricular dilated cardiomyopathy.
100 项与 Heartpoint Global Ltd. 相关的临床结果
0 项与 Heartpoint Global Ltd. 相关的专利(医药)
100 项与 Heartpoint Global Ltd. 相关的药物交易
100 项与 Heartpoint Global Ltd. 相关的转化医学